Your AI-Trained Oncology Knowledge Connection!

The Evolving Landscape in Mantle Cell Lymphoma

home / peer-exchange / the-evolving-landscape-in-mantle-cell-lymphoma

Accurately Diagnosing Mantle Cell Lymphoma

EP. 1: Accurately Diagnosing Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

January 19th 2021

Treatment Approaches in Mantle Cell Lymphoma

EP. 2: Treatment Approaches in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

January 19th 2021

Go-To Treatment Regimens in Mantle Cell Lymphoma

EP. 3: Go-To Treatment Regimens in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

January 26th 2021

Lenalidomide and Bortezomib for Mantle Cell Lymphoma

EP. 4: Lenalidomide and Bortezomib for Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

January 26th 2021

BTK Inhibitors for Relapsed Mantle Cell Lymphoma

EP. 5: BTK Inhibitors for Relapsed Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 2nd 2021

Acalabrutinib and Zanubrutinib for Relapsed MCL

EP. 6: Acalabrutinib and Zanubrutinib for Relapsed MCL

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 2nd 2021

Selecting a BTKi for Relapsed MCL Treatment

EP. 7: Selecting a BTKi for Relapsed MCL Treatment

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 9th 2021

BTK Inhibitors for Relapsed MCL: Important Considerations

EP. 8: BTK Inhibitors for Relapsed MCL: Important Considerations

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 9th 2021

Venetoclax in Mantle Cell Lymphoma

EP. 9: Venetoclax in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 16th 2021

CAR T-Cell Therapy for R/R Mantle Cell Lymphoma

EP. 10: CAR T-Cell Therapy for R/R Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 16th 2021

Emerging BTK Inhibitors in Mantle Cell Lymphoma

EP. 11: Emerging BTK Inhibitors in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 23rd 2021

MCL: Emerging BTKi-Combination Approaches

EP. 12: MCL: Emerging BTKi-Combination Approaches

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 23rd 2021

Novel Therapies in the Pipeline in Mantle Cell Lymphoma

EP. 13: Novel Therapies in the Pipeline in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

MRD Assessment in Mantle Cell Lymphoma

EP. 14: MRD Assessment in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

Next Steps in Mantle Cell Lymphoma

EP. 15: Next Steps in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

Latest Conference Coverage

Talazoparib Plus Enzalutamide Improves rPFS Regardless of AR Alteration Status in mCRPC

Olaparib Plus Pembrolizumab Shows Efficacy in HRR Gene–Mutated Advanced Tumors With/Without HRD Positivity

First-Line Penpulimab Plus Chemo Extends PFS in Recurrent or Metastatic Nasopharyngeal Carcinoma

TARA-002 Showcases Early Clinical Activity in BCG-Naive and -Unresponsive High-Risk NMIBC

View More Latest Conference Coverage

Editorial Board

MJH Life Sciences brands

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.